Study: Lactation consultants improve breast-feeding rates
NEW YORK — In two separate clinical trials, researchers at Albert Einstein College of Medicine of Yeshiva University have found that periodic meetings with a lactation consultant encourages women traditionally resistant to breast-feeding to do so, at least for a few months, or long enough for mother and child to gain health benefits. The results of the trials were published online last week in American Journal of Public Health.
The American Academy of Pediatrics recommends exclusive breastfeeding for the first six months after birth, followed by continued breast-feeding for one year or longer as other foods are introduced. However, according to the Centers for Disease Control and Prevention, fewer than 75% of infants nationwide are breastfed at all and fewer than half are still being breast-fed at six months. Health benefits of breast-feeding can include reduced incidence of ear infections, stomach illness and lower obesity rates for children and, for mothers, a reduced risk for pre-menopausal breast cancer, type 2 diabetes and heart disease.
In one of the two trials included in this paper, women who were regularly encouraged and given instruction and support for breast-feeding were more than four times as likely to exclusively breast-feed their infant at one month and nearly three times more likely to do so at three months, compared with the control group.
"The effects of the interventions in our trials — and our use of lactation consultants in particular — were more impressive than those reported by two recent reviews that evaluated the effects of the numerous previous trials aimed at improving breast-feeding rates," stated Karen Bonuck, professor of family and social medicine and of obstetrics and gynecology and women’s health at Einstein.
Some of the lowest rates of breast-feeding are known to occur among Black/non-Hispanic, younger, overweight and less-educated mothers — together those women made up a large majority of those enrolled in the two trials. Patients included in the trials received their care at Montefiore Medical Center, Einstein’s University Hospital.
"Two-thirds of the women in the trials were either overweight or obese, which means they’re not inclined to breast feed," Bonuck said. "There are physical difficulties with the baby latching on, many of these women have difficulty producing enough milk, and there may be psychological barriers as well. Yet we showed that support from a lactation consultant significantly improves their chances of breast-feeding for three months — sufficient time for mother and baby to obtain important health benefits."
USA Today investigative report: Many companies masquerading products as dietary supplements run by criminals
ARLINGTON, Va. — A USA TODAY investigation on Friday found that many of those companies marketing dietary supplement containing with drug-spiked products are run by people with criminal backgrounds and regulatory run-ins.
The crimes range from those involving illicit drugs, including barbiturates, crack cocaine, Ecstasy and other narcotics, to arrests for selling or possessing steroids and human growth hormone.
"Other supplement company executives have records of fraud, theft, assault, weapons offenses, money laundering or other offenses," USA Today reported.
Flu-like activity picking up across South
ATLANTA — This year’s influenza virus is beginning its prominence in the South, as Alabama, Louisiana, Mississippi and Texas reported high influenza-like illness activity, the Centers for Disease Control and Prevention reported Friday.
Oklahoma reported moderate ILI activity.
For those who got a flu shot this year, so far they appear to be well protected.
CDC has antigenically characterized 317 influenza viruses, including 265 2009 H1N1 viruses, 46 influenza A (H3N2) viruses and 6 influenza B viruses since Oct. 1.
All 265 2009 H1N1 viruses tested were characterized as A/California/7/2009-like, the influenza A (H1N1) component of the 2013-2014 Northern Hemisphere influenza vaccine. Likewise, all 46 influenza A (H3N2) viruses tested have been characterized as A/Texas/50/2012-like, the influenza A (H3N2) component of the 2013-2014 Northern Hemisphere influenza vaccine.
Two of the six influenza B viruses tested belong to B/Yamagata/16/88-lineage and the remaining four influenza B viruses tested belong to B/Victoria/02/87 lineage.
The two influenza B/Yamagata-lineage viruses were characterized as B/ Massachusetts/2/1012-like, which is included as an influenza B component of the 2013-2014 Northern Hemisphere trivalent and quadrivalent influenza vaccines.
And the four influenza B/Victoria-lineage viruses were characterized as B/Brisbane/60/2008-like, which is included as an influenza B component of the 2013-2014 Northern Hemisphere quadrivalent influenza vaccine.